BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for June 7, 2023

June 7, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Airway, Allovir, Anavex, Bpgbio, Cali, Defender, Galapagos, Glaukos, Harmony, Mereo, Okyo, Orsobio, Repare, Sareum, Tiziana, Ultragenyx, Vaxart, Vaxxas.
Read More

Financings for June 7, 2023

June 7, 2023
Biopharmas raising money in public or private financings, including: Bitterroot, Cogent, Day One, Effector, Hopewell, Ionis, Kiora, Mozart, Newamsterdam, Nrx, Transcode, Vaxart.
Read More

Appointments and advancements for June 7, 2023

June 7, 2023
New hires and promotions in the biopharma industry, including: Abivax, Amarna, Chemomab, Entera, Lobe, Mekanistic, Nkilt, Nona, Ring, Satellos, XNK.
Read More

Regulatory actions for June 6, 2023

June 6, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advanced Medical Solutions, Artelon, Avatar Medical, Deepx Diagnostics.
Read More

Other news to note for June 6, 2023

June 6, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accustem, Artoss, Biocomposites, Detect-Ion, Gore, General Graphene, GE Healthcare, Graphenedx, Ixlayer, Masimo, Pathmaker Neurosystems, Porter, Sapphiros.
Read More

In the clinic for June 6, 2023

June 6, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Activ Surgical, Natera, Neogenomics.
Read More

Financings for June 6, 2023

June 6, 2023
Med-tech firms raising money in public or private financings, including: Telesis Bio, Volitionrx.
Read More

Appointments and advancements for June 6, 2023

June 6, 2023
New hires and promotions in the med-tech industry, including: Cypher Surgical, CN Bio, Imperative Care, Irhythm, Nevro, Medcura, Zephyr AI.
Read More

Regulatory actions for May 30-June 5, 2023

June 6, 2023
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Amarin, American Regent, Ascentage, Astrazeneca, Beigene, Biophytis, Canbridge, Cocrystal, Daiichi Sankyo, Eddingpharm, Gilead, Hutchmed, Innovent, Inventiva, Novavax, Sino, SK, Takeda.
Read More

Other news to note for June 6, 2023

June 6, 2023
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adcendo, Affamed, Affyxell, Avacta, Bioray, Biosenic, Celltrion, Cleave, Daewoong, Duality, Impact, J Ints, Jiangsu Nhwa, Lotus, Medsenic, Nascent, Neurogastrx, Nrx, Phebra, Philogen, Rani, Seven and Eight, Sun, Trevena, Yuhan.
Read More
Previous 1 2 … 766 767 768 769 770 771 772 773 774 … 1790 1791 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing